WHO technical guidance and specifications of medical devices for screening and treatment of precancerous lesions in the prevention of cervical cancer

Globally, 311,000 women die of cervical cancer every year, 85 percent of them in resource limited regions of the world. To address this grave threat to women, the WHO made a call to action in 2018, resulting in accelerated plans to improve cervical cancer control under the elimination threshold with respect to cervical cancer incidence. As part of WHO’s approach to cervical cancer control, availability of high quality, affordable medical devices for HPV screening, and treatment of precancerous lesions in low resource settings is indispensable.